OM Outset Medical, Inc. logo

OM Outset Medical, Inc.

Healthcare
$4.32+1.41%ClosedMarket Cap: $80.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.71

P/S

0.68

EV/EBITDA

-0.86

DCF Value

$-69.90

FCF Yield

-42.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

40.6%

Operating Margin

-56.9%

Net Margin

-63.7%

ROE

-55.9%

ROA

-30.0%

ROIC

-31.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$27.9M$-19.0M$
Q4 null$28.9M$-19.5M$
FY null$119.5M$-81.7M$
Q3 null$29.4M$-17.8M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$10.00

Target (Median)

$8.00

Target Range

$7.00 - $15.00

0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
BTIGBuy
2026-02-12
StifelBuy
2026-01-07
BTIGBuy
2025-12-16
BTIGBuy
2025-11-11
RBC CapitalSector Perform
2025-11-11

Trading Activity

Insider Trades

View All
Trigg Lesliedirector, officer: Chair and CEO
SellTue May 19
Nash Marcofficer: EVP Operations R&D & Service
SellTue May 19
Brottem John L.officer: General Counsel
SellTue May 19
Leonard Braden Michael10 percent owner
SellMon May 18
Leonard Braden Michael10 percent owner
SellTue May 12

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.91

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Peers